Summit Therapeutics Stock News: A Breakthrough in Cancer Therapy Recent developments have put Summit Therapeutics stock in the…

This article When was the last time a new drug humbled the world’s best? Summit Therapeutics Stock To Explode 🧬 appeared first on Guerilla Stock Trading.

Telomir Pharmaceuticals (TELO) has recently gained significant attention following a local ABC exclusive that showcased impressive results from their novel "age reversal" pill in two senior dogs. This compassionate use study has sparked interest in Telomir's stock.

This article What if you could ‘grow younger’? Meet the new pill that’s redefining what’s possible for aging bodies, starting with our furry friends! 🧬 appeared first on Guerilla Stock Trading.

The Approval Without an Emergency In a move that has sparked considerable debate, the FDA approved a new…

This article FDA approves new COVID-19 vaccine for babies… but there’s no emergency? What’s really going on? 🤔 appeared first on Guerilla Stock Trading.

On August 6, 2024, TG Therapeutics’ stock witnessed a significant rise, fueled by several positive financial and operational…

This article Briumvi’s success story: FDA approval, market expansion, and 5,850 new prescriptions! Is TG Therapeutics your next top stock pick? 🔬 appeared first on Guerilla Stock Trading.

On July 30, 2024, Imunon (IMNN) stock surged by 258.5% following the release of positive results from the…

This article 🔬 A game-changer in cancer treatment! Imunon’s latest trial results show an 11.1-month increase in survival 📊 appeared first on Guerilla Stock Trading.

Zevra Therapeutics’ (ZVRA) stock has recently risen due to several key factors. The FDA accepted the resubmission of…

This article Zevra Therapeutics’ Stock Surge: A Comprehensive Analysis appeared first on Guerilla Stock Trading.

Anavex Life Sciences (AVXL) has experienced a notable surge in its stock price, driven by several key factors.…

This article Major Gains for Anavex Life Sciences! Find Out Why Their Lead Therapy Could Revolutionize Alzheimer’s Treatment! 🌟 appeared first on Guerilla Stock Trading.

Viking Therapeutics’ stock surged in after-hours trading on July 24, 2024, due to several positive developments. The company…

This article Viking Therapeutics is on fire! Q2 earnings beat expectations and obesity treatment advances to Phase 3! 🚀 appeared first on Guerilla Stock Trading.

GRI Bio’s (GRI) stock is currently generating significant interest due to several recent developments. The company announced a…

This article Mark your calendars! Interim data for GRI-0621’s Phase 2a study expected in Q3 2024—Will it meet expectations? 🗓️ appeared first on Guerilla Stock Trading.

Delcath Systems (DCTH) stock has surged due to several positive developments. The stock increased by 65.71% over the…

This article Game-Changing Tech in Healthcare! Over 20 cancer centers adopting HEPZATO KIT—this is a big deal for investors! 🏥 appeared first on Guerilla Stock Trading.

Nutriband (NTRB) has seen a notable rise in its stock price due to several key factors. The company…

This article Nutriband just saw an 11.18% surge in a single day! With a decline in short interest and positive moving averages, is this your next big buy? 💸 appeared first on Guerilla Stock Trading.

Intuitive Surgical (ISRG) has shown robust stock performance due to several key factors. In Q1 2024, the company…

This article Want to know why ISRG is the stock to watch? Check out their latest advancements and financial growth! 💸 appeared first on Guerilla Stock Trading.

Immutep (NASDAQ: IMMP) has experienced substantial stock gains driven by several key developments. Notably, the TACTI-003 Phase IIb…

This article Immutep’s groundbreaking trials in head and neck cancer are yielding incredible results—Investors buzzing! 🔬 appeared first on Guerilla Stock Trading.

Kazia Therapeutics (KZIA) stock has surged due to positive Phase II/III clinical trial results for paxalisib, a brain…

This article Kazia Therapeutics’ stock just skyrocketed! What’s behind this 300% surge? 🚀 appeared first on Guerilla Stock Trading.

Positive Interim Data from Mid-Stage Trial On Monday, Ideaya Biosciences (IDYA) witnessed a significant surge in its stock…

This article IDEAYA Biosciences’ stock skyrockets 23% with groundbreaking clinical trial results! 📈 appeared first on Guerilla Stock Trading.

The FDA approved a new Alzheimer’s drug, Kisunla, from Eli Lilly, following unanimous recommendation by an expert panel.…

This article Finally! A New Hope for Alzheimer’s Patients – FDA Approves Kisunla 🙌 appeared first on Guerilla Stock Trading.

Novavax (NVAX) has been making headlines with its remarkable stock performance, driven by several critical factors. The company’s…

This article Novavax’s new vaccine just changed the game—non-mRNA solution 💉 appeared first on Guerilla Stock Trading.

Sarepta Therapeutics’ stock is rising due to its inclusion in the S&P MidCap 400, expanded FDA approval for…

This article FDA Approval Game-Changer: Sarepta’s Elevidys gene therapy just got a green light—huge impact on the stock! ✅ appeared first on Guerilla Stock Trading.

Thermo Fisher Scientific (TMO), a leading life sciences company, is experiencing growth due to the expanding GLP-1 drug…

This article Drug approvals are skyrocketing! Why Thermo Fisher is the go-to partner for the biggest breakthroughs 💊 appeared first on Guerilla Stock Trading.

In a groundbreaking study published in Cell, researchers used artificial intelligence (AI) to predict nearly one million new…

This article AI Discovers Nearly 1 Million New Antibiotics – A Game Changer in the Fight Against Superbugs! appeared first on Guerilla Stock Trading.

Amphastar Pharmaceuticals is experiencing a bullish trend reversal following their strong Q1 2024 financial performance. The company reported…

This article Amphastar’s product portfolio is thriving – discover how this pharma giant is conquering new markets! appeared first on Guerilla Stock Trading.

ImmunityBio Inc. (IBRX) has recently achieved a significant milestone in the field of cancer therapy. In April 2024,…

This article ImmunityBio’s Breakthrough: FDA Approval for Bladder Cancer Therapy appeared first on Guerilla Stock Trading.

In a significant development for medical and personal device maker Philips (PHG), the company has reached a monumental…

This article Philips Settles Respironics Litigation for $1.1 Billion: A Turning Point Amidst Sluggish Q1 Results appeared first on Guerilla Stock Trading.

ImmunityBio (IBRX) announced positive results from the QUILT 3.055 study evaluating ANKTIVA (N-803) in 2nd- and 3rd-line NSCLC…

This article Breaking Cancer Barriers: ImmunityBio’s ANKTIVA Triumph appeared first on Guerilla Stock Trading.

In the realm of cancer treatment, advancements in cellular therapies have been causing waves of excitement and anticipation.…

This article The Potential Expansion of CAR-T Therapies: FDA Decision Looms appeared first on Guerilla Stock Trading.